Study identifier:D5133N00007
ClinicalTrials.gov identifier:NCT03212287
EudraCT identifier:N/A
CTIS identifier:N/A
Brilinta tablets 60mg/90mg Clinical Experience Investigation
acute coronary syndrome, old myocardial infarction
N/A
No
-
All
566
Observational
16 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jul 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|